|
Clinical Preventive Services -
Screening - Neoplastic Diseases -
Prostate Cancer
ACPM Recommendations:
The American College of Preventive
Medicine recommends against routine
population screening with digital rectal
exams and prostate-specific antigen. Men
age 50 or older with a life expectancy
of greater than 10 years should be given
information about the potential benefits
and harms of screening and limits of
current evidence and should be allowed
to make their own choice about
screening, in consultation with their
physician, based on personal
preferences. Methods and tools for
helping patients review this information
are available, however, the ACPM
recommends further research be conducted
in optimizing the process of patient
education and informed consent.
- See the entire ACPM recommendation
in:
Screening for Prostate Cancer in
American Men.
Rebecca L. Ferrini, MD, MPH, University
of California/California State
University and Steven H. Woolf, MD,
FACPM, Medical College of Virginia. Am J
Prev Med. July 1998.
U.S. Preventive Services Task Force
Recommendations:
Routine screening for prostate cancer
with digital rectal examinations, serum
tumor markers (e.g., prostate-specific
antigen), or transrectal ultrasound is
not recommended.
|
